Literature DB >> 24352659

Host SAMHD1 protein promotes HIV-1 recombination in macrophages.

Laura A Nguyen1, Dong-Hyun Kim, Michele B Daly, Kevin C Allan, Baek Kim.   

Abstract

Template switching can occur during the reverse transcription of HIV-1. Deoxynucleotide triphosphate (dNTP) concentrations have been biochemically shown to impact HIV-1 reverse transcriptase (RT)-mediated strand transfer. Lowering the dNTP concentrations promotes RT pausing and RNA template degradation by RNase H activity of the RT, subsequently leading to strand transfer. Terminally differentiated/nondividing macrophages, which serve as a key HIV-1 reservoir, contain extremely low dNTP concentrations (20-50 nm), which results from the cellular dNTP hydrolyzing sterile α motif and histidine aspartic domain containing protein 1 (SAMHD1) protein, when compared with activated CD4(+) T cells (2-5 μm). In this study, we first observed that HIV-1 template switching efficiency was nearly doubled in human primary macrophages when compared with activated CD4(+) T cells. Second, SAMHD1 degradation by viral protein X (Vpx), which elevates cellular dNTP concentrations, decreased HIV-1 template switching efficiency in macrophages to the levels comparable with CD4(+) T cells. Third, differentiated SAMHD1 shRNA THP-1 cells have a 2-fold increase in HIV-1 template switching efficiency. Fourth, SAMHD1 degradation by Vpx did not alter HIV-1 template switching efficiency in activated CD4(+) T cells. Finally, the HIV-1 V148I RT mutant that is defective in dNTP binding and has DNA synthesis delay promoted RT stand transfer when compared with wild type RT, particularly at low dNTP concentrations. Here, we report that SAMHD1 regulation of the dNTP concentrations influences HIV-1 template switching efficiency, particularly in macrophages.

Entities:  

Keywords:  HIV-1; Homologous Recombination; Macrophages; Nucleotide; Reverse Transcription; SAMHD1; Vpx

Mesh:

Substances:

Year:  2013        PMID: 24352659      PMCID: PMC3908385          DOI: 10.1074/jbc.C113.522326

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.

Authors:  Rebecca D Powell; Paul J Holland; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

2.  Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages.

Authors:  Baek Kim; Laura A Nguyen; Waaqo Daddacha; Joseph A Hollenbaugh
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

3.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

4.  Frequent incorporation of ribonucleotides during HIV-1 reverse transcription and their attenuated repair in macrophages.

Authors:  Edward M Kennedy; Sarah M Amie; Robert A Bambara; Baek Kim
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

5.  Altered strand transfer activity of a multiple-drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutant with a dipeptide fingers domain insertion.

Authors:  Laura A Nguyen; Waaqo Daddacha; Sean Rigby; Robert A Bambara; Baek Kim
Journal:  J Mol Biol       Date:  2011-11-12       Impact factor: 5.469

6.  The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus.

Authors:  Henning Hofmann; Eric C Logue; Nicolin Bloch; Waaqo Daddacha; Sylvie B Polsky; Megan L Schultz; Baek Kim; Nathaniel R Landau
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

7.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.

Authors:  Hichem Lahouassa; Waaqo Daddacha; Henning Hofmann; Diana Ayinde; Eric C Logue; Loïc Dragin; Nicolin Bloch; Claire Maudet; Matthieu Bertrand; Thomas Gramberg; Gianfranco Pancino; Stéphane Priet; Bruno Canard; Nadine Laguette; Monsef Benkirane; Catherine Transy; Nathaniel R Landau; Baek Kim; Florence Margottin-Goguet
Journal:  Nat Immunol       Date:  2012-02-12       Impact factor: 25.606

8.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

9.  SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons.

Authors:  Corine St Gelais; Suresh de Silva; Sarah M Amie; Christopher M Coleman; Heather Hoy; Joseph A Hollenbaugh; Baek Kim; Li Wu
Journal:  Retrovirology       Date:  2012-12-11       Impact factor: 4.602

10.  Restriction of diverse retroviruses by SAMHD1.

Authors:  Thomas Gramberg; Tanja Kahle; Nicolin Bloch; Sabine Wittmann; Erik Müllers; Waaqo Daddacha; Henning Hofmann; Baek Kim; Dirk Lindemann; Nathaniel R Landau
Journal:  Retrovirology       Date:  2013-03-05       Impact factor: 4.602

View more
  7 in total

1.  Pre-steady state kinetic analysis of HIV-1 reverse transcriptase for non-canonical ribonucleoside triphosphate incorporation and DNA synthesis from ribonucleoside-containing DNA template.

Authors:  Laura A Nguyen; Robert A Domaoal; Edward M Kennedy; Dong-Hyun Kim; Raymond F Schinazi; Baek Kim
Journal:  Antiviral Res       Date:  2014-12-31       Impact factor: 5.970

2.  TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.

Authors:  Fan Wu; Ilnour Ourmanov; Nadeene Riddick; Kenta Matsuda; Sonya Whitted; Ronald J Plishka; Alicia Buckler-White; Matthew F Starost; Vanessa M Hirsch
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

3.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02

4.  Novel inhibitors of human immunodeficiency virus type 2 infectivity.

Authors:  Lauren B Beach; Jonathan M Rawson; Baek Kim; Steven E Patterson; Louis M Mansky
Journal:  J Gen Virol       Date:  2014-08-07       Impact factor: 3.891

5.  A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library.

Authors:  Caryll Waugh; Deborah Cromer; Andrew Grimm; Abha Chopra; Simon Mallal; Miles Davenport; Johnson Mak
Journal:  Virol J       Date:  2015-04-09       Impact factor: 4.099

Review 6.  Retroviral vectors for analysis of viral mutagenesis and recombination.

Authors:  Jonathan M O Rawson; Louis M Mansky
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

7.  HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells.

Authors:  Deborah Cromer; Timothy E Schlub; Redmond P Smyth; Andrew J Grimm; Abha Chopra; Simon Mallal; Miles P Davenport; Johnson Mak
Journal:  Viruses       Date:  2016-04-22       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.